These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11964916)

  • 41. [Antibiotic resistance in respiratory tract infections: what can we do?].
    Flückiger U
    Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An update on the pharmacotherapeutic management of lower respiratory tract infections.
    Cazzola M; Rogliani P; Aliberti S; Blasi F; Matera MG
    Expert Opin Pharmacother; 2017 Jul; 18(10):973-988. PubMed ID: 28480770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs.
    Watson RL; Dowell SF; Jayaraman M; Keyserling H; Kolczak M; Schwartz B
    Pediatrics; 1999 Dec; 104(6):1251-7. PubMed ID: 10585974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of lower respiratory tract infections in out-patients.
    Woodhead M
    Monaldi Arch Chest Dis; 1997 Oct; 52(5):486-91. PubMed ID: 9510671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-duration therapy for respiratory tract infections.
    Goff DA
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S19-23. PubMed ID: 15226490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: an evidence-based consensus by the Italian Society of Preventive and Social Pediatrics.
    Chiappini E; Mazzantini R; Bruzzese E; Capuano A; Colombo M; Cricelli C; Di Mauro G; Esposito S; Festini F; Guarino A; Miniello VL; Principi N; Marchisio P; Rafaniello C; Rossi F; Sportiello L; Tancredi F; Venturini E; Galli L; de Martino M;
    Paediatr Respir Rev; 2014 Sep; 15(3):231-6. PubMed ID: 24666567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prescription and consumption of antibiotics in ambulatory care].
    Presse Med; 1999 Feb; 28(7):343-50. PubMed ID: 10083880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current issues in the management of bacterial respiratory tract disease: the challenge of antibacterial resistance.
    Dunbar LM
    Am J Med Sci; 2003 Dec; 326(6):360-8. PubMed ID: 14671500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care.
    Steinman MA; Landefeld CS; Gonzales R
    JAMA; 2003 Feb; 289(6):719-25. PubMed ID: 12585950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistant pathogens in respiratory tract infections in older people.
    Bonomo RA
    J Am Geriatr Soc; 2002 Jul; 50(7 Suppl):S236-41. PubMed ID: 12121519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing use of antibiotics in community-based outpatient practice, 1991-1999.
    Steinman MA; Gonzales R; Linder JA; Landefeld CS
    Ann Intern Med; 2003 Apr; 138(7):525-33. PubMed ID: 12667022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guideline for the management of upper respiratory tract infections.
    Brink AJ; Cotton MF; Feldman C; Geffen L; Hendson W; Hockman MH; Maartens G; Madhi SA; Mutua-Mpungu M; Swingler GH;
    S Afr Med J; 2004 Jun; 94(6 Pt 2):475-83. PubMed ID: 15244257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
    Garau J
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A critical assessment of published guidelines and other decision-support systems for the antibiotic treatment of community-acquired respiratory tract infections.
    Finch RG; Low DE
    Clin Microbiol Infect; 2002; 8 Suppl 2():69-91. PubMed ID: 12427208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antimicrobial use in acute upper respiratory infections in family medicine].
    Ramírez Villaseñor I
    Rev Med Inst Mex Seguro Soc; 2005; 43(3):247-55. PubMed ID: 16138460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sense and nonsense in antibiotic therapy for respiratory tract infections].
    Domej W; Flögel E; Tilz GP; Demel U
    Internist (Berl); 2005 Jul; 46(7):795-9. PubMed ID: 15815891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical management of respiratory tract infections in the community: experience with telithromycin.
    Quintiliani R
    Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines.
    Zwar N; Wolk J; Gordon J; Sanson-Fisher R; Kehoe L
    Fam Pract; 1999 Oct; 16(5):495-500. PubMed ID: 10533946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.